Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute for Health Research, United Kingdom | OTHER_GOV |
| Institute of Cancer Research, United Kingdom | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Numerous surveys have shown that following breast surgery, longterm pain affects around half of patients. Given that 1 in 9 women will get breast cancer and that surgery is the cornerstone of treatment, persistent pain represents a major challenge. In addition to the suffering chronic pain causes to individual patients, the investigators know that it places a substantial burden on families and carers, and that patients with pain represent an excessive demand on healthcare resources.
This research will evaluate the impact of introducing a proactive, integrated care plan for patients having breast surgery. It will assess the effect of the care plan on reducing the number of patients with pain at 3 and 12 months after their procedure.
The personalised plan involves numerous evidence based steps linked by a single unifying description aimed at controlling pain, before, during and after the procedure, in hospital and at home.
Patients at risk of developing pain will be identified prior to the procedure and randomly allocated to follow either the personalised care plan or to receive 'usual' care. In the personalised care plan group, participants will get information about chronic pain, be screened for pain and offered immediate treatment. During their procedure both the surgeon and the anaesthetist will offer treatments such as nerve numbing procedures that reduce the likelihood of experiencing pain.
After their procedure, patients will be again screened for pain and further treatment instigated. Physiotherapists and other allied health professionals such as psychologists will also be involved as appropriate. A package of care for pain will then be passed on to the patients' GP, in the form of a written pain management plan, for ongoing care which will be linked to the hospital. Patients from both groups will be followed up for a year at regular intervals.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention limb | Active Comparator | Medical review and analgesic optimisation. Pain education (in the form of leaflet and website recommendations) Psychological input for patients with evidence of psychological morbidity. Protective analgesia - one pre-procedure dose of 150mg oral pregabalin. Five days post-procedure oral pregablin twice daily at a dose of 75mg twice a day. Patients offered a paravertebral block, local anaesthetic infiltrated around the wound by the surgeon. Daily, focused visits from the hospital pain team. Any patient displaying concerning pain symptoms, behaviour or who underwent prolonged (>3 hours surgery) may be booked for early 'preemptive' review in pain clinic. |
|
| Usual care | No Intervention | These partcipants will receive usual care before, during and after their breast surgery |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Protective analgesia | Drug | Participants in the intervention arm of the study (if no contraindications exist) will be administered one pre-procedure dose of 150mg of oral pregabalin. For a total of five days post-procedure the participants in the intervention limb of the study will take oral pregablin twice daily at a dose of 75mg twice a day. |
| Measure | Description | Time Frame |
|---|---|---|
| Difference in pain scores (as indicated by a pain severity index score) in the intervention group compared to the 'usual care' group. | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| The difference in levels of anxiety and depression (versus 'usual care') measured by the hospital anxiety and depression scale (HADS) | 3 and 12 months | |
| The difference in general health outcomes (versus 'usual care') determined by the EQ5D questionnaire |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| JOHN E WILLIAMS, MB BS FRCA | The Royal Marsden Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Royal Marsden Hospital | London | London | SW3 6JJ | United Kingdom |
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Pain education | Other | Participant will receive a pain education leaflet |
|
| Psychological support | Behavioral | Participants demonstrating psychological morbidity will be offered psychological support prior to surgery |
|
| Paravertebral block/local anaesthetic infiltration | Procedure | Patients on the intervention limb will be encouraged to have a paravertebral block if not contraindicated |
|
| Daily visits from pain team whilst in hospital | Other |
|
| 3 and 12 months |
| The difference in participant satisfaction (versus 'usual care') determined by the Global Surgical Recovery (GSR) Scale. | 3 and 12 months |
| ID | Term |
|---|---|
| D009437 | Neuralgia |
| D000072716 | Cancer Pain |
| D000377 | Agnosia |
| ID | Term |
|---|---|
| D010523 | Peripheral Nervous System Diseases |
| D009468 | Neuromuscular Diseases |
| D009422 | Nervous System Diseases |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069583 | Pregabalin |
| D006761 | Hospitals |
| ID | Term |
|---|---|
| D005680 | gamma-Aminobutyric Acid |
| D000613 | Aminobutyrates |
| D002087 | Butyrates |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
| D000596 | Amino Acids |
| D000602 | Amino Acids, Peptides, and Proteins |
| D006268 | Health Facilities |
| D005159 | Health Care Facilities Workforce and Services |
Not provided
Not provided